Prevalence, Treatment Patterns, and Outcomes of Individuals with <i>EGFR</i> Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion <i>EGFR</i> Mutation Carriers

Prevalence, Treatment Patterns, and Outcomes of Individuals with <i>EGFR</i> Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion <i>EGFR</i> Mutation Carriers

Real-world evidence surrounding <i>EGFR</i> positive NSCLC patients in Canada is limited. Administrative databases in Alberta, Canada were used to evaluate <i>EGFR</i> testing and mutation prevalence in de novo metastatic NSCLC, as well as the characteristics, treatment patte...

Full description

Bibliographic Details
Main Authors: Dylan E. O’Sullivan, Tamer N. Jarada, Amman Yusuf, Leo (Xun Yang) Hu, Priyanka Gogna, Darren R. Brenner, Erica Abbie, Jennifer B. Rose, Kiefer Eaton, Julia Elia-Pacitti, Emmanuel M. Ewara, Aliyah Pabani, Winson Y. Cheung, Devon J. Boyne
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Current Oncology
Subjects:
non-small cell lung cancer
epidermal growth factor
genomic testing
healthcare resource use
real world evidence
Online Access:https://www.mdpi.com/1718-7729/29/10/567

Internet

https://www.mdpi.com/1718-7729/29/10/567

Similar Items